These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 29111299)
1. Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia. Ohno-Matsui K; Ikuno Y; Lai TYY; Gemmy Cheung CM Prog Retin Eye Res; 2018 Mar; 63():92-106. PubMed ID: 29111299 [TBL] [Abstract][Full Text] [Related]
2. Anti-VEGF Therapy in Myopic CNV. Toto L; Di Antonio L; Costantino O; Mastropasqua R Curr Drug Targets; 2021; 22(9):1054-1063. PubMed ID: 33511955 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopia. Pakzad-Vaezi K; Mehta H; Mammo Z; Tufail A Expert Opin Biol Ther; 2016 Jul; 16(7):873-81. PubMed ID: 26985834 [TBL] [Abstract][Full Text] [Related]
4. Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management. Cheung CMG; Arnold JJ; Holz FG; Park KH; Lai TYY; Larsen M; Mitchell P; Ohno-Matsui K; Chen SJ; Wolf S; Wong TY Ophthalmology; 2017 Nov; 124(11):1690-1711. PubMed ID: 28655539 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology and Diagnosis of Myopic Choroidal Neovascularization in Asia. Chan NS; Teo K; Cheung CM Eye Contact Lens; 2016 Jan; 42(1):48-55. PubMed ID: 26448447 [TBL] [Abstract][Full Text] [Related]
6. Anti-Vascular Endothelial Growth Factor Therapy for Myopic Choroidal Neovascularization. Ng DSC; Lai TYY; Cheung CMG; Ohno-Matsui K Asia Pac J Ophthalmol (Phila); 2017; 6(6):554-560. PubMed ID: 29057641 [TBL] [Abstract][Full Text] [Related]
7. Ranibizumab for myopic choroidal neovascularization. Ng DSC; Fung NSK; Yip FLT; Lai TYY Expert Opin Biol Ther; 2020 Dec; 20(12):1385-1393. PubMed ID: 33003962 [TBL] [Abstract][Full Text] [Related]
8. The role of anti-VEGF agents in myopic choroidal neovascularization: Current standards and future outlook. Munk MR; Rückert R; Zinkernagel M; Ebneter A; Wolf S Expert Opin Biol Ther; 2016; 16(4):477-87. PubMed ID: 26666589 [TBL] [Abstract][Full Text] [Related]
9. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization. Ahn SJ; Park KH; Woo SJ Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5794-800. PubMed ID: 26325418 [TBL] [Abstract][Full Text] [Related]
10. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION. Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235 [TBL] [Abstract][Full Text] [Related]
11. Antivascular endothelial growth factor for choroidal neovascularization in pathologic myopia. Battaglia Parodi M; Iacono P; Bandello F Dev Ophthalmol; 2010; 46():73-83. PubMed ID: 20703033 [TBL] [Abstract][Full Text] [Related]
12. CHOROIDAL THICKNESS AND CHORIORETINAL ATROPHY IN MYOPIC CHOROIDAL NEOVASCULARIZATION WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. Lee JH; Lee SC; Kim SH; Koh HJ; Kim SS; Byeon SH; Lee CS Retina; 2017 Aug; 37(8):1516-1522. PubMed ID: 27798519 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab. Yang HS; Kim JG; Kim JT; Joe SG Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429 [TBL] [Abstract][Full Text] [Related]
14. Improved Visual Outcome and Low Recurrence with Early Treatment with Intravitreal Anti-Vascular Endothelial Growth Factor in Myopic Choroidal Neovascularization. Moon BG; Cho AR; Lee J; Kim YJ; Lee JY; Kim JG; Yoon YH Ophthalmologica; 2017; 237(3):128-138. PubMed ID: 28278507 [TBL] [Abstract][Full Text] [Related]
15. Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application. Zhang Y; Han Q; Ru Y; Bo Q; Wei RH Drug Des Devel Ther; 2015; 9():3413-21. PubMed ID: 26170626 [TBL] [Abstract][Full Text] [Related]